Introduction: Understanding Long Acting Insulin
Diabetes is a chronic condition that affects millions of people worldwide. It requires careful management to maintain optimal blood sugar levels and prevent complications. One crucial aspect of diabetes management is insulin therapy. Long acting insulin, also known as basal insulin, plays a vital role in providing a steady release of insulin throughout the day. In this article, we will explore the various aspects of long acting insulin, including how it works, different types, administration techniques, monitoring blood sugar levels, and more.
How Long Acting Insulin Works
Long acting insulin is designed to mimic the basal insulin secretion produced by the pancreas in individuals without diabetes. Its primary function is to provide a continuous and steady release of insulin, helping to control blood sugar levels between meals and overnight. Unlike rapid-acting insulins, which act quickly but have a shorter duration of action, long acting insulin works gradually and lasts for an extended period.
Types of Long Acting Insulin
Basal Insulin
Basal insulin is the generic term for long acting insulins that provide a constant level of insulin throughout the day. It acts as a background insulin, maintaining a stable blood sugar level between meals and during periods of fasting. Basal insulin is typically administered once or twice a day, depending on the individual’s needs and the specific insulin prescribed.
Insulin Glargine (Lantus)
Insulin glargine, commonly marketed under the brand name Lantus, is a popular long acting insulin analog. It is designed to release slowly and evenly over a 24-hour period, providing a steady level of insulin to manage blood sugar levels. Lantus has a duration of action of up to 24 hours and does not have a pronounced peak, resulting in a more predictable insulin response.
Insulin Detemir (Levemir)
Insulin detemir, known by the brand name Levemir, is another long acting insulin analog. It has a duration of action of up to 24 hours, providing a consistent basal insulin level throughout the day. Levemir offers flexibility in dosing and can be administered once or twice daily, depending on individual requirements. It also has a lower risk of hypoglycemia compared to some other long acting insulins.
Insulin Degludec (Tresiba)
Insulin degludec, marketed as Tresiba, is a newer long acting insulin analog known for its extended duration of action. Tresiba has a half-life of up to 25 hours, allowing for once-daily dosing. It provides a stable and continuous insulin release, with the added benefit of flexibility in injection timing. Tresiba is known for its long and consistent action profile, making it an attractive option for individuals with diabetes.
For more info click here!
